tiprankstipranks
Advertisement
Advertisement

AU:NX1 Stock Latest News

Nexalis Therapeutics Requests Trading Halt Ahead of Debt Funding Update
Company AnnouncementsNexalis Therapeutics Requests Trading Halt Ahead of Debt Funding Update
4d ago
NX1
Nexalis Therapeutics reshapes board as director steps down
PremiumCompany Announcements
Nexalis Therapeutics reshapes board as director steps down
13d ago
NX1
Nexalis Therapeutics Sets Virtual AGM to Vote on Board, Pay and Capital Mandates
PremiumCompany Announcements
Nexalis Therapeutics Sets Virtual AGM to Vote on Board, Pay and Capital Mandates
26d ago
NX1
Nexalis Therapeutics Sets Online-Only 2026 AGM and Moves to Digital Meeting Materials
PremiumCompany Announcements
Nexalis Therapeutics Sets Online-Only 2026 AGM and Moves to Digital Meeting Materials
26d ago
NX1
Nexalis calls virtual AGM with pay vote, potential board spill
PremiumCompany Announcements
Nexalis calls virtual AGM with pay vote, potential board spill
26d ago
NX1
Nexalis Boosts Cash Reserves Despite R&D-Driven Outflows
PremiumCompany AnnouncementsNexalis Boosts Cash Reserves Despite R&D-Driven Outflows
26d ago
NX1
Nexalis shifts to active trial execution as rebrand caps pipeline expansion
Premium
Company Announcements
Nexalis shifts to active trial execution as rebrand caps pipeline expansion
26d ago
NX1
Nexalis Advances Inhaled CBD Anxiety Drug to Final Phase 1 Cohort
Premium
Company Announcements
Nexalis Advances Inhaled CBD Anxiety Drug to Final Phase 1 Cohort
28d ago
NX1
Nexalis Screens First Patient in Phase 2 IRX-211 Trial for Breakthrough Cancer Pain
PremiumCompany Announcements
Nexalis Screens First Patient in Phase 2 IRX-211 Trial for Breakthrough Cancer Pain
1M ago
NX1
Nexalis Advances Phase 1 Trial of Inhaled CBD Therapy for Panic Disorder
PremiumCompany Announcements
Nexalis Advances Phase 1 Trial of Inhaled CBD Therapy for Panic Disorder
1M ago
NX1
Nexalis Therapeutics Confirms Corporate Structure and ASX Listing in Annual Report
PremiumCompany Announcements
Nexalis Therapeutics Confirms Corporate Structure and ASX Listing in Annual Report
2M ago
NX1
Nexalis Therapeutics Details Governance Framework and ASX Compliance
PremiumCompany Announcements
Nexalis Therapeutics Details Governance Framework and ASX Compliance
2M ago
NX1
Nexalis to Showcase Inhaled Therapy Pipeline at NWR Virtual Healthcare Conference
PremiumCompany AnnouncementsNexalis to Showcase Inhaled Therapy Pipeline at NWR Virtual Healthcare Conference
2M ago
NX1
Nexalis starts first-in-human trial of inhaled CBD therapy for panic disorder
Premium
Company Announcements
Nexalis starts first-in-human trial of inhaled CBD therapy for panic disorder
2M ago
NX1
Nexalis starts first-in-human trial of inhaled CBD therapy for panic disorder
Premium
Company Announcements
Nexalis starts first-in-human trial of inhaled CBD therapy for panic disorder
3M ago
NX1
Nexalis Therapeutics Loss Widens as Net Tangible Assets Slide Further
PremiumCompany Announcements
Nexalis Therapeutics Loss Widens as Net Tangible Assets Slide Further
3M ago
NX1
Nexalis Issues New Shares as It Accelerates Clinical Drug Programs
PremiumCompany Announcements
Nexalis Issues New Shares as It Accelerates Clinical Drug Programs
3M ago
NX1
Nexalis Therapeutics Seeks ASX Quotation for 780,000 New Shares
PremiumCompany Announcements
Nexalis Therapeutics Seeks ASX Quotation for 780,000 New Shares
3M ago
NX1
Nexalis Therapeutics Plans Placement of 780,000 New Shares
PremiumCompany Announcements
Nexalis Therapeutics Plans Placement of 780,000 New Shares
3M ago
NX1
Nexalis pays advisory fees in shares to preserve cash for clinical pipeline
PremiumCompany AnnouncementsNexalis pays advisory fees in shares to preserve cash for clinical pipeline
3M ago
NX1

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >